PRKDC and cancer: We also demonstrate that this phosphorylation is decreased following pharmacologic inhibition of DNA-PK in the gastric cancer cell line GTL-16 as well as the lung cancer cell line EBC-1, two MET receptor-addicted cancer cell lines characterized by an amplified MET gene copy number [24–26].